BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28752649)

  • 1. Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine.
    Stohs SJ
    Phytother Res; 2017 Oct; 31(10):1463-1474. PubMed ID: 28752649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Safety of Oral p-Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo-Controlled Cross-over Clinical Trial.
    Shara M; Stohs SJ; Mukattash TL
    Phytother Res; 2016 May; 30(5):842-7. PubMed ID: 26948284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract.
    Kaats GR; Miller H; Preuss HG; Stohs SJ
    Food Chem Toxicol; 2013 May; 55():358-62. PubMed ID: 23354394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Citrus aurantium (bitter orange) fruit extracts and p-synephrine on metabolic fluxes in the rat liver.
    Peixoto JS; Comar JF; Moreira CT; Soares AA; de Oliveira AL; Bracht A; Peralta RM
    Molecules; 2012 May; 17(5):5854-69. PubMed ID: 22592089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synephrine in dietary supplements and specialized foodstuffs: biological activity, safety and methods of analysis].
    Perova IB; Eller KI; Musatov AV; Tymolskaya EV
    Vopr Pitan; 2021; 90(6):101-113. PubMed ID: 35032130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Published Bitter Orange Extract and
    Stohs SJ; Ray SD
    J Diet Suppl; 2020; 17(3):355-363. PubMed ID: 30835576
    [No Abstract]   [Full Text] [Related]  

  • 9. Physiological effects following administration of Citrus aurantium for 28 days in rats.
    Hansen DK; George NI; White GE; Pellicore LS; Abdel-Rahman A; Fabricant D;
    Toxicol Appl Pharmacol; 2012 Jun; 261(3):236-47. PubMed ID: 22521485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans.
    Seifert JG; Nelson A; Devonish J; Burke ER; Stohs SJ
    Int J Med Sci; 2011 Mar; 8(3):192-7. PubMed ID: 21448304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects.
    Stohs SJ; Preuss HG; Shara M
    Oxid Med Cell Longev; 2011; 2011():482973. PubMed ID: 21904645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study.
    Shara M; Stohs SJ; Smadi MM
    Phytother Res; 2018 Jan; 32(1):125-131. PubMed ID: 29130542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium).
    Nelson BC; Putzbach K; Sharpless KE; Sander LC
    J Agric Food Chem; 2007 Nov; 55(24):9769-75. PubMed ID: 17966980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPLC-UV-QDa analysis of Citrus aurantium-labelled pre-workout supplements suggest only a minority contain the plant extract.
    Koh AHW; Chess-Williams R; Lohning AE
    J Pharm Biomed Anal; 2021 Jan; 193():113746. PubMed ID: 33190081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isopropylnorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium.
    Mercader J; Wanecq E; Chen J; Carpéné C
    J Physiol Biochem; 2011 Sep; 67(3):443-52. PubMed ID: 21336650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk assessment of synephrine in dietary supplements].
    Bakhyia N; Dusemund B; Richter K; Lindtner O; Hirsch-Ernst KI; Schäfer B; Lampen A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):323-331. PubMed ID: 28058460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of bitter orange dietary supplements for natural and synthetic phenethylamines by LC-MS/MS.
    Pawar RS; Sagi S; Leontyev D
    Drug Test Anal; 2020 Sep; 12(9):1241-1251. PubMed ID: 32497396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid liquid chromatography electrospray ionization mass spectrometry(n) method for evaluation of synephrine in Citrus aurantium L. samples.
    Mattoli L; Cangi F; Maidecchi A; Ghiara C; Tubaro M; Traldi P
    J Agric Food Chem; 2005 Dec; 53(26):9860-6. PubMed ID: 16366666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain?
    Allison DB; Cutter G; Poehlman ET; Moore DR; Barnes S
    Int J Obes (Lond); 2005 Apr; 29(4):443-6. PubMed ID: 15700046
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.